New Issue: Science’s Impossible Questions. Read Now

Getting It Right on Stem Cells

Why hundreds of embryonic stem cell lines aren't enough

Join Our Community of Science Lovers!

This fall funding for embryonic stem cell research once again faces uncertainty. In August a federal district court judge blocked the use of federal funds for any project that would destroy embryos. In September a higher court restored funding temporarily, while it considers an appeal by the Justice Department. We offer a guide to the facts behind the controversy:

Where do the embryos used for stem cell lines come from?
All stem cell lines come from discarded IVF embryos. Currently there are around 400,000 embryos stored at fertility clinics around the country.

How many stem cell lines are there?
A stem cell line is a family of constantly dividing cells produced from a group of parent cells that were harvested from a single embryo. M. William Lensch, a scientist at the Harvard Stem Cell Institute, estimates there are 800 lines around the world.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Why isn’t this enough?
In theory, one stem cell line can supply an infinite number of researchers indefinitely. But despite their omnipotent potential, embryonic stem cells are a finicky lot. Some have a tendency to grow into liver cells, others into blood, and others into nerve, pancreas or heart tissue. Sometimes the differences are caused by known factors, such as embryo age or protein contamination, but more frequently they are not understood. “For some projects, existing lines work very well, but for others, not at all,” Lensch says.

Why aren’t more unused embryos made into cell lines?
Whereas some 60 percent of infertility patients would like to donate their unused embryos to research, a dearth of funding and an uncertain regulatory environment have muddied the process. “Everything is at a stand­still right now,” says Elena Gates, director of the IVF tissue bank at the University of California, San Francisco.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe